You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
|
---|---|
Published in |
Journal for Immunotherapy of Cancer, May 2019
|
DOI | 10.1186/s40425-019-0600-6 |
Pubmed ID | |
Authors |
Yixin Zhou, Zuan Lin, Xuanye Zhang, Chen Chen, Hongyun Zhao, Shaodong Hong, Li Zhang |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 41% |
Netherlands | 2 | 12% |
Japan | 1 | 6% |
China | 1 | 6% |
Colombia | 1 | 6% |
Italy | 1 | 6% |
Unknown | 4 | 24% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 47% |
Scientists | 4 | 24% |
Practitioners (doctors, other healthcare professionals) | 4 | 24% |
Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 68 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 8 | 12% |
Student > Master | 7 | 10% |
Researcher | 7 | 10% |
Student > Doctoral Student | 6 | 9% |
Student > Bachelor | 5 | 7% |
Other | 11 | 16% |
Unknown | 24 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 32% |
Biochemistry, Genetics and Molecular Biology | 7 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 9% |
Nursing and Health Professions | 3 | 4% |
Immunology and Microbiology | 1 | 1% |
Other | 3 | 4% |
Unknown | 26 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2019.
All research outputs
#4,230,658
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,118
of 3,424 outputs
Outputs of similar age
#81,633
of 362,900 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#36
of 74 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,900 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.